Fluidigmâs saliva based RT-PCR kit receives approval in India 24 December 2020 | News Source credit: Fluidigm With the increased reliance on saliva based testing, US based Fluidigm has revealed that its Advanta Dx SARS-COV-2 RT-PCR kit, which is a saliva based diagnostic test has been authorized for use in India. This kit facilitates SARS-CoV-2 detection from saliva samples easing the sample collection process & eliminating the need for Viral RNA extraction process. The kit is compatible with Fluidigm’s high-throughput Biomark HD platform. Fluidigm claims that with certain configurations, the Biomark HD system can run a maximum of 6000 samples and controls per day.